© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
December 05, 2020
New data from an ongoing trial showed patients achieved MRD negative status after a vaccine regimen—and have maintained status over a year.
Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.
Early assessment from an Australian team of investigators is targeting a pathway linked to hemoglobin expression.
High levels of fetal hemoglobin have previously been linked to the mitigation of morbidity and mortality of sickle cell anemia.
Those without prior exposure to venetoclax experienced the most benefit.
December 04, 2020
Diabetic patients are more susceptible to severe COVID-19 outcomes.
Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.
This combination therapy may have a few advantages over standard corticosteroid regimens.
The indication is based on 48-week results showing significant benefit in reduced HAE attacks among pediatric and adult patients.
December 03, 2020
Patients with normal eGFR increased from 60% at baseline to 80% at 3 years following procedure.